Two Sigma Securities, LLC Plus Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.27 - $0.48 $4,670 - $8,303	-17,298 Reduced 42.45%	23,449 $6,000
Q4 2022 Feb 14, 2023	SELL	$0.3 - $8.4 $7,008 - $196,224	-23,360 Reduced 36.44%	40,747 $13,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $7.5 $30,771 - $480,802	64,107 New	64,107 $29,000
Q1 2022 May 16, 2022	SELL	$0.87 - $1.32 $12,170 - $18,465	-13,989 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.03 - $1.94 $14,408 - $27,138	13,989 New	13,989 $15,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $36.3M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.